Augmented cytotoxicity of estramustine and etoposide combination in hormone refractory prostate cancer cell lines and association with TGF modulation

被引：0
|
作者：
LN Türkeri
O Ayaz
M Özyürek
A Akdas
机构：
[1] ‘Ergun Özalp’ Research Laboratory,Department of Urology
[2] Marmara University School of Medicine,undefined
来源：
Prostate Cancer and Prostatic Diseases | 1999年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：S33 / S33
相关论文
共 50 条
  • [21] Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer
    Smith, DC
    Esper, P
    Strawderman, M
    Redman, B
    Pienta, KJ
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1664 - 1671
  • [22] Weekly paclitaxel plus estramustine combination therapy in hormone-refractory prostate cancer: A pilot study
    Kuruma, H
    Fujita, T
    Shitara, T
    Egawa, S
    Yokoyama, E
    Baba, S
    INTERNATIONAL JOURNAL OF UROLOGY, 2003, 10 (09) : 470 - 475
  • [23] Weekly docetaxel and estramustine in patients with hormone-refractory prostate cancer
    Copur, MS
    Ledakis, P
    Lynch, J
    Hauke, R
    Tarantolo, S
    Bolton, M
    Norvell, M
    Muhvic, J
    Hake, L
    Wendt, J
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 16 - 21
  • [24] PHASE-II EVALUATION OF ORAL ESTRAMUSTINE AND ORAL ETOPOSIDE IN HORMONE-REFRACTORY ADENOCARCINOMA OF THE PROSTATE
    PIENTA, KJ
    REDMAN, B
    HUSSAIN, M
    CUMMINGS, G
    ESPER, PS
    APPEL, C
    FLAHERTY, LE
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) : 2005 - 2012
  • [25] Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate
    Mackler, Niklas J.
    Dunn, Rodney L.
    Hellerstedt, Beth
    Cooney, Kathleen A.
    Fardig, Judith
    Olson, Karin
    Pienta, Kenneth J.
    Smith, David C.
    CANCER, 2006, 106 (12) : 2617 - 2623
  • [26] Effect of estramustine, etoposide, and taxol on prostate cancer cell growth in vitro and in vivo
    Pienta, KJ
    Naik, H
    Lehr, JE
    UROLOGY, 1996, 48 (01) : 164 - 170
  • [27] Weekly paclitaxel plus estramustine phosphate in hormone-refractory prostate cancer
    Roth, BJ
    Hudes, GR
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 137 - 137
  • [28] WEEKLY EPIRUBICIN PLUS ORAL ESTRAMUSTINE IN METASTATIC HORMONE REFRACTORY PROSTATE CANCER
    Ramus, Guido Vietti
    Tonda, Laura
    Sirgiovanni, Marianna Paola
    ANNALS OF ONCOLOGY, 2004, 15 : 95 - 95
  • [29] PACLITAXEL PLUS ESTRAMUSTINE IN METASTATIC HORMONE-REFRACTORY PROSTATE-CANCER
    HUDES, GR
    NATHAN, FE
    KHATER, C
    GREENBERG, R
    GOMELLA, L
    STERN, C
    MCALEER, C
    SEMINARS IN ONCOLOGY, 1995, 22 (05) : 41 - 45
  • [30] Vinorelbine (VNB) and estramustine (EMP) in hormone-refractory prostate cancer (HRPC).
    Ferraù, F
    Morgia, G
    Priolo, D
    Vitale, F
    Parisi, A
    Mattina, M
    Calì, S
    ANNALS OF ONCOLOGY, 2000, 11 : 77 - 77
12345